Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.53 USD | +1.10% | +3.38% | +12.68% |
Apr. 29 | Transcript : Capricor Therapeutics, Inc. - Special Call | |
Apr. 24 | Capricor Therapeutics Gets Another Type-B Meeting With FDA for Duchenne Muscular Dystrophy Investigational Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.68% | 172M | |
+8.89% | 105B | |
-0.66% | 104B | |
+5.79% | 22.94B | |
-12.83% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-8.89% | 16.96B | |
+7.98% | 14.16B | |
+39.20% | 12.63B |
- Stock Market
- Equities
- CAPR Stock
- News Capricor Therapeutics, Inc.
- Capricor Therapeutics Gets Another Type-B Meeting With FDA for Duchenne Muscular Dystrophy Investigational Drug